Category Dossier
Life & Style.
Strategic updates and verified intelligence from the Life & Style vertical.
Top Featured
Life & Style
Lipfendra (enlicitide): The New Once-Daily Oral PCSK9 Inhibitor
The FDA just gave the green light for Lipfendra, which is enlicitide. It’s a big deal because it’s the first time we have a once-daily oral PCSK9 inhibitor available for adults dealing with certain types of high cholesterol. Merck developed this pill. It offers a new route. A way around those pesky
Jul 17, 2026 by Gree News Team